Shilpa Medicare’s JV Oncosol and partner Shorla Oncology gets US FDA approval for IMKELDI

Share it

IMKELDI is the first oral liquid form of imatinib used to treat certain forms of leukemia and other cancers.

Leave a Comment

Your email address will not be published. Required fields are marked *